LucaPlex® Life Science

Luca offers our partners the technology to accelerate clinical trials using digital endpoints;
make therapeutics safer and more effective through our AI-powered digital companion solutions.

Digital companion

We help our partners develop and commercialize novel digital companion technologies that enhance traditional drug therapies.

  • Diagnosis companion
    Identify more patients using highly accessible digital biomarker technologies
  • Treatment companion
    AI-guided recommendations for dosage optimization and exacerbation prediction based on shifts in disease progression
  • Rehabilitation companion
    Personalized rehabilitation guidance to further improve clinical benefits

Clinical trial solutions

Our platform allows our partners to implement appropriate digital endpoints in clinical trials, offering previously inaccessible accuracy and unattainable insights. Ultimately, reduce a drug’s time to market and total cost of clinical trials.

  • Improved trial efficiency
  • Reduced number of participants
  • Improved analysis to therapeutic response